Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
20,505,656
-
Total 13F shares
-
2,145,805
-
Share change
-
+107,342
-
Total reported value
-
$8,111,390
-
Put/Call ratio
-
0%
-
Price per share
-
$3.78
-
Number of holders
-
20
-
Value change
-
+$183,530
-
Number of buys
-
8
-
Number of sells
-
8
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q2 2022
As of 30 Jun 2022,
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,145,805 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ACT CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, BlackRock Inc., MORGAN STANLEY, and ARTHUR M. COHEN & ASSOCIATES, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.